Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Friedrich

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Neurosurgery. Pediatrics|June 19, 2026
Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trialKara L Krajewski, Gertrud Kammler, Denise Obrecht-Sturm, et al.
Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
Genome Medicine|May 9, 2025
Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumorJenny Wegert, Silke Appenzeller, Taryn D Treger, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Neurosurgery. Pediatrics|June 19, 2026
Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trialKara L Krajewski, Gertrud Kammler, Denise Obrecht-Sturm, et al.
Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
Genome Medicine|May 9, 2025
Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumorJenny Wegert, Silke Appenzeller, Taryn D Treger, et al.
Pageof 6